 | • レポートコード：MRC2-11QY12004 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は胃炎治療薬のグローバル市場について調査・分析したレポートです。種類別（酸遮断薬、抗生物質、制酸剤、ヒスタミン遮断薬、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別胃炎治療薬の競争状況、市場シェア ・世界の胃炎治療薬市場：種類別市場規模 2015年-2020年（酸遮断薬、抗生物質、制酸剤、ヒスタミン遮断薬、その他） ・世界の胃炎治療薬市場：種類別市場規模予測 2021年-2026年（酸遮断薬、抗生物質、制酸剤、ヒスタミン遮断薬、その他） ・世界の胃炎治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界の胃炎治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米の胃炎治療薬市場分析：米国、カナダ ・ヨーロッパの胃炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの胃炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の胃炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの胃炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、AstraZeneca、Novartis、Cipla、Abbott Laboratories、Microbiotix、Reddy's Laboratories、Lupin Ltd、Perrigo Pharmaceutical、Sun Pharmaceutical Industries ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and heartburn. Complications may include bleeding, stomach ulcers, and stomach tumors.
The Americas is going to account for the largest share for gastritis treatment market. Drivers such as widespread of fast food chains in this region along with the increasing sedentary life culture which in turn contributes to increasing patient pool of gastritis and rising geriatric population are likely to enhance the growth of gastritis treatment market.
Market Analysis and Insights: Global Gastritis Therapeutics Market
The global Gastritis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Gastritis Therapeutics Scope and Market Size
Gastritis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastritis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
AstraZeneca
Novartis
Cipla
Abbott Laboratories
Microbiotix
Reddy’s Laboratories
Lupin Ltd
Perrigo Pharmaceutical
Sun Pharmaceutical Industries
Market segment by Type, the product can be split into
Acid-Blocking Medicines
Antibiotics
Antacids
Histamine Blockers
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastritis Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Gastritis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Acid-Blocking Medicines
1.4.3 Antibiotics
1.4.4 Antacids
1.4.5 Histamine Blockers
1.4.6 Others
1.5 Market by Application
1.5.1 Global Gastritis Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Gastritis Therapeutics Market Perspective (2015-2026)
2.2 Global Gastritis Therapeutics Growth Trends by Regions
2.2.1 Gastritis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastritis Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Gastritis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gastritis Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Gastritis Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Gastritis Therapeutics Players by Market Size
3.1.1 Global Top Gastritis Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Gastritis Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Gastritis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastritis Therapeutics Market Concentration Ratio
3.2.1 Global Gastritis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gastritis Therapeutics Revenue in 2019
3.3 Gastritis Therapeutics Key Players Head office and Area Served
3.4 Key Players Gastritis Therapeutics Product Solution and Service
3.5 Date of Enter into Gastritis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastritis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Gastritis Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Gastritis Therapeutics Market Size by Application (2015-2020)
5.2 Global Gastritis Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gastritis Therapeutics Market Size (2015-2020)
6.2 Gastritis Therapeutics Key Players in North America (2019-2020)
6.3 North America Gastritis Therapeutics Market Size by Type (2015-2020)
6.4 North America Gastritis Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gastritis Therapeutics Market Size (2015-2020)
7.2 Gastritis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Gastritis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Gastritis Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Gastritis Therapeutics Market Size (2015-2020)
8.2 Gastritis Therapeutics Key Players in China (2019-2020)
8.3 China Gastritis Therapeutics Market Size by Type (2015-2020)
8.4 China Gastritis Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gastritis Therapeutics Market Size (2015-2020)
9.2 Gastritis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Gastritis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Gastritis Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gastritis Therapeutics Market Size (2015-2020)
10.2 Gastritis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastritis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Gastritis Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Gastritis Therapeutics Market Size (2015-2020)
11.2 Gastritis Therapeutics Key Players in India (2019-2020)
11.3 India Gastritis Therapeutics Market Size by Type (2015-2020)
11.4 India Gastritis Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gastritis Therapeutics Market Size (2015-2020)
12.2 Gastritis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastritis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Gastritis Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Gastritis Therapeutics Introduction
13.1.4 Pfizer Revenue in Gastritis Therapeutics Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview
13.2.3 AstraZeneca Gastritis Therapeutics Introduction
13.2.4 AstraZeneca Revenue in Gastritis Therapeutics Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Gastritis Therapeutics Introduction
13.3.4 Novartis Revenue in Gastritis Therapeutics Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Cipla
13.4.1 Cipla Company Details
13.4.2 Cipla Business Overview
13.4.3 Cipla Gastritis Therapeutics Introduction
13.4.4 Cipla Revenue in Gastritis Therapeutics Business (2015-2020)
13.4.5 Cipla Recent Development
13.5 Abbott Laboratories
13.5.1 Abbott Laboratories Company Details
13.5.2 Abbott Laboratories Business Overview
13.5.3 Abbott Laboratories Gastritis Therapeutics Introduction
13.5.4 Abbott Laboratories Revenue in Gastritis Therapeutics Business (2015-2020)
13.5.5 Abbott Laboratories Recent Development
13.6 Microbiotix
13.6.1 Microbiotix Company Details
13.6.2 Microbiotix Business Overview
13.6.3 Microbiotix Gastritis Therapeutics Introduction
13.6.4 Microbiotix Revenue in Gastritis Therapeutics Business (2015-2020)
13.6.5 Microbiotix Recent Development
13.7 Reddy’s Laboratories
13.7.1 Reddy’s Laboratories Company Details
13.7.2 Reddy’s Laboratories Business Overview
13.7.3 Reddy’s Laboratories Gastritis Therapeutics Introduction
13.7.4 Reddy’s Laboratories Revenue in Gastritis Therapeutics Business (2015-2020)
13.7.5 Reddy’s Laboratories Recent Development
13.8 Lupin Ltd
13.8.1 Lupin Ltd Company Details
13.8.2 Lupin Ltd Business Overview
13.8.3 Lupin Ltd Gastritis Therapeutics Introduction
13.8.4 Lupin Ltd Revenue in Gastritis Therapeutics Business (2015-2020)
13.8.5 Lupin Ltd Recent Development
13.9 Perrigo Pharmaceutical
13.9.1 Perrigo Pharmaceutical Company Details
13.9.2 Perrigo Pharmaceutical Business Overview
13.9.3 Perrigo Pharmaceutical Gastritis Therapeutics Introduction
13.9.4 Perrigo Pharmaceutical Revenue in Gastritis Therapeutics Business (2015-2020)
13.9.5 Perrigo Pharmaceutical Recent Development
13.10 Sun Pharmaceutical Industries
13.10.1 Sun Pharmaceutical Industries Company Details
13.10.2 Sun Pharmaceutical Industries Business Overview
13.10.3 Sun Pharmaceutical Industries Gastritis Therapeutics Introduction
13.10.4 Sun Pharmaceutical Industries Revenue in Gastritis Therapeutics Business (2015-2020)
13.10.5 Sun Pharmaceutical Industries Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Gastritis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Gastritis Therapeutics Revenue
Table 3. Ranking of Global Top Gastritis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gastritis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acid-Blocking Medicines
Table 6. Key Players of Antibiotics
Table 7. Key Players of Antacids
Table 8. Key Players of Histamine Blockers
Table 9. Key Players of Others
Table 10. Global Gastritis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Gastritis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Gastritis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Gastritis Therapeutics Market Share by Regions (2015-2020)
Table 14. Global Gastritis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Gastritis Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Gastritis Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Gastritis Therapeutics Players
Table 21. Global Gastritis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Gastritis Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top Gastritis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastritis Therapeutics as of 2019)
Table 24. Global Gastritis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Gastritis Therapeutics Product Solution and Service
Table 27. Date of Enter into Gastritis Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Gastritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Gastritis Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global Gastritis Therapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Gastritis Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global Gastritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Gastritis Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Gastritis Therapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Gastritis Therapeutics Market Share (2019-2020)
Table 37. North America Gastritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Gastritis Therapeutics Market Share by Type (2015-2020)
Table 39. North America Gastritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Gastritis Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Gastritis Therapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Gastritis Therapeutics Market Share (2019-2020)
Table 43. Europe Gastritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Gastritis Therapeutics Market Share by Type (2015-2020)
Table 45. Europe Gastritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Gastritis Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Gastritis Therapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Gastritis Therapeutics Market Share (2019-2020)
Table 49. China Gastritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Gastritis Therapeutics Market Share by Type (2015-2020)
Table 51. China Gastritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Gastritis Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Gastritis Therapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Gastritis Therapeutics Market Share (2019-2020)
Table 55. Japan Gastritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Gastritis Therapeutics Market Share by Type (2015-2020)
Table 57. Japan Gastritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Gastritis Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Gastritis Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Gastritis Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia Gastritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Gastritis Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Gastritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Gastritis Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Gastritis Therapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Gastritis Therapeutics Market Share (2019-2020)
Table 67. India Gastritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Gastritis Therapeutics Market Share by Type (2015-2020)
Table 69. India Gastritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Gastritis Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Gastritis Therapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Gastritis Therapeutics Market Share (2019-2020)
Table 73. Central & South America Gastritis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Gastritis Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Gastritis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Gastritis Therapeutics Market Share by Application (2015-2020)
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Product
Table 80. Pfizer Revenue in Gastritis Therapeutics Business (2015-2020) (Million US$)
Table 81. Pfizer Recent Development
Table 82. AstraZeneca Company Details
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Product
Table 85. AstraZeneca Revenue in Gastritis Therapeutics Business (2015-2020) (Million US$)
Table 86. AstraZeneca Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Product
Table 90. Novartis Revenue in Gastritis Therapeutics Business (2015-2020) (Million US$)
Table 91. Novartis Recent Development
Table 92. Cipla Company Details
Table 93. Cipla Business Overview
Table 94. Cipla Product
Table 95. Cipla Revenue in Gastritis Therapeutics Business (2015-2020) (Million US$)
Table 96. Cipla Recent Development
Table 97. Abbott Laboratories Company Details
Table 98. Abbott Laboratories Business Overview
Table 99. Abbott Laboratories Product
Table 100. Abbott Laboratories Revenue in Gastritis Therapeutics Business (2015-2020) (Million US$)
Table 101. Abbott Laboratories Recent Development
Table 102. Microbiotix Company Details
Table 103. Microbiotix Business Overview
Table 104. Microbiotix Product
Table 105. Microbiotix Revenue in Gastritis Therapeutics Business (2015-2020) (Million US$)
Table 106. Microbiotix Recent Development
Table 107. Reddy's Laboratories Company Details
Table 108. Reddy's Laboratories Business Overview
Table 109. Reddy's Laboratories Product
Table 110. Reddy's Laboratories Revenue in Gastritis Therapeutics Business (2015-2020) (Million US$)
Table 111. Reddy's Laboratories Recent Development
Table 112. Lupin Ltd Business Overview
Table 113. Lupin Ltd Product
Table 114. Lupin Ltd Company Details
Table 115. Lupin Ltd Revenue in Gastritis Therapeutics Business (2015-2020) (Million US$)
Table 116. Lupin Ltd Recent Development
Table 117. Perrigo Pharmaceutical Company Details
Table 118. Perrigo Pharmaceutical Business Overview
Table 119. Perrigo Pharmaceutical Product
Table 120. Perrigo Pharmaceutical Revenue in Gastritis Therapeutics Business (2015-2020) (Million US$)
Table 121. Perrigo Pharmaceutical Recent Development
Table 122. Sun Pharmaceutical Industries Company Details
Table 123. Sun Pharmaceutical Industries Business Overview
Table 124. Sun Pharmaceutical Industries Product
Table 125. Sun Pharmaceutical Industries Revenue in Gastritis Therapeutics Business (2015-2020) (Million US$)
Table 126. Sun Pharmaceutical Industries Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastritis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Acid-Blocking Medicines Features
Figure 3. Antibiotics Features
Figure 4. Antacids Features
Figure 5. Histamine Blockers Features
Figure 6. Others Features
Figure 7. Global Gastritis Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Gastritis Therapeutics Report Years Considered
Figure 12. Global Gastritis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Gastritis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Gastritis Therapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Gastritis Therapeutics Market Share by Players in 2019
Figure 17. Global Top Gastritis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastritis Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Gastritis Therapeutics Revenue in 2019
Figure 19. North America Gastritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Gastritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Gastritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Gastritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Gastritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Gastritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Gastritis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
胃炎治療の世界市場（～2026年） Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and …- 萎縮性胃炎治療の世界市場（～2026年） Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity dire…
- 肥大型心筋症治療薬の世界市場（～2026年） HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ, and cardiomyopathy refers …
- 胃食道逆流症（GERD）治療薬の世界市場（～2026年） Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications. Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attrib…
- 核酸ベース治療薬の世界市場（～2026年） Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of…